Target intelligence / Profile preview

Photoreceptor cell-specific nuclear receptor (NR2E3)

Target
NR2E3
Molecular classification
Nuclear receptor, Transcription factor
01

Overview

The photoreceptor cell-specific nuclear receptor (**PNR**), encoded by the **NR2E3** gene, is a member of the nuclear receptor superfamily of intracellular transcription factors[1][5]. It is expressed exclusively in the retina, where it promotes rod photoreceptor specification and maintenance by regulating the transcription of genes such as rhodopsin and various opsins essential for sight[1][3][5]. Crystal structures reveal a functional ligand-binding domain that generally maintains PNR in a repressor state, but can be modulated by small molecules[1]. Mutations in NR2E3 lead to several inherited retinal degenerative diseases, notably enhanced S-cone syndrome, Goldmann-Favre syndrome, and types of retinitis pigmentosa, typically via abnormal photoreceptor differentiation or maintenance[1][5][9]. There are candidate modulatory drugs, including retinoids and synthetic allosteric regulators, that may provide new treatments for retinitis pigmentosa by refining NR2E3-mediated transcriptional control[1].

Other names
Photoreceptor-specific nuclear receptor (PNR)Nuclear receptor subfamily 2, group E, member 3NR2E3phNR2E3
02

Mechanism of action

Ligand binding modulates transcriptional activity affecting expression of photoreceptor-specific genes; Synthetic and natural ligands can act as agonists, allosteric modulators, or reverse agonists

03

Biological functions

Photoreceptor differentiationRetinal developmentRegulation of phototransductionPromotion of cellular differentiation
04

Disease associations

Retinal degenerationRetinitis pigmentosaEnhanced S-cone syndromeGoldmann-Favre syndromeClumped pigmentary retinal degeneration
05

Safety considerations

No systemic toxicity identified for targeting NR2E3, but therapeutic modulation could affect retinal cell differentiation and survival, leading to vision impact if not precisely controlled
06

Interacting drugs

13-cis retinoic acid (weak agonist)

2 more in the full profile.

07

Biomarkers

Enlarged/delayed S-cone electroretinographic (ERG) responsesS-cone to L/M-cone ratioNR2E3 sequence variants for inherited retinal disease diagnostics

Beyond the preview

Go deeper on Photoreceptor cell-specific nuclear receptor (NR2E3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Photoreceptor cell-specific nuclear receptor (NR2E3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call